A phase II study of irinotecan (CPT-11) and carboplatin in patients with limited disease small cell lung cancer (SCLC)-Reference-Cited by-同舟云学术

A phase II study of irinotecan (CPT-11) and carboplatin in patients with limited disease small cell lung cancer (SCLC)

Published:2007-08 Issue:2 Volume:57 Page:181-186
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Laack Eckart,Thöm Ina,Krüll Andreas,Engel-Riedel Walburga,Müller Thomas,Meißner Christoph,Dürk Heinz,Fischer Jürgen,Gütz Sylvia,Kortsik Cornelius,Elbers Matthias,Schuch Gunter,Andritzky Birte,Görn Michael,Burkholder Iris,Edler Lutz,Hossfeld Dieter Kurt,Bokemeyer Carsten

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference22 articles.

1. Intensive combined modality therapy for limited-disease small cell lung cancer;Elias;J Natl Cancer Inst,1993

2. Small cell lung cancer: state of the art;Hanna;Clin Lung Cancer,2002

3. A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis;Mascaux;Lung Cancer,2000

4. Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small cell lung cancer: Cancer and Leukemia Group B trial 9732;Niell;J Clin Oncol,2005

5. A phase II trial of imatinib (STI 571) in patients with c-kit expressing relapsed small cell lung cancer: a CALGB and NCCTG study;Dy;Ann Oncol,2005

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population Survival Kinetics Derived from Clinical Trials of Potentially Curable Lung Cancers;Current Oncology;2024-03-20

2. Irinotecan and Carboplatin (IC) Regimen for Small-Cell Lung Cancer and Non-Small-Cell Lung Cancer;Hospital Pharmacy;2014-07

3. Phase II Study of Induction Cisplatin and Irinotecan Followed by Concurrent Carboplatin, Etoposide, and Thoracic Radiotherapy for Limited-Stage Small-Cell Lung Cancer, CALGB 30206;Journal of Thoracic Oncology;2013-01

4. Irinotecan and Carboplatin (IC) Regimen for Lung Cancer;Hospital Pharmacy;2009-09

5. Local enzymatic hydrolysis of an endogenously generated metabolite can enhance CPT-11 anticancer efficacy;Molecular Cancer Therapeutics;2009-04